Company Filing History:
3 out of 1,777 
1 out of 4 
1 out of 3 Years Active: 2021-2025
Title: The Innovations of Ladislav Droz
Introduction
Ladislav Droz is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of chemistry, particularly in the development of glucose-sensitive albumin-binding derivatives. With a total of four patents to his name, Droz's work has the potential to impact various medical applications.
Latest Patents
One of his latest patents focuses on glucose-sensitive albumin-binding diboron conjugates. This invention provides novel diboron compounds, specifically diboronate or diboroxole compounds, which are useful as intermediate compounds for the synthesis of diboron conjugates. This innovative approach could lead to advancements in drug delivery systems and therapeutic applications.
Career Highlights
Throughout his career, Droz has worked with prominent companies such as Novo Nordisk A/S and Vysoká Škola Chemicko-Technologická v Praze. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the field of chemistry.
Collaborations
Droz has collaborated with esteemed colleagues, including Thomas Kruse and Mikael Kofod-Hansen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Ladislav Droz's contributions to the field of chemistry through his patents and collaborations highlight his role as a significant inventor. His work on glucose-sensitive albumin-binding derivatives showcases the potential for advancements in medical applications.